Relationship Between Psychiatric Drug Use and Cognitive Function in Women During the Menopausal Transition: An Analysis Based on the NHANES Database
- 1Department of Pharmacy, The Second Hospital of Dalian Medical University, 116023 Dalian, Liaoning, China
Abstract
Background:: Women during the menopausal transition often experience mood disorders, sleep disturbances, and cognitive decline, making the use of psychotropic drugs relatively common. However, the relationship between psychiatric drug use and cognitive function in menopausal women remains unclear.
Methods:: This was a cross-sectional study that included women aged 45–65 years from the National Health and Nutrition Examination Survey (NHANES) 2021–2023 cycle. Psychiatric drug use was defined based on prescription drug data, including antidepressants, benzodiazepines, and sedative-hypnotics. Cognitive function was assessed using the Digit Symbol Substitution Test (DSST). The Bayesian Kernel Machine Regression model was used to analyse the relationship between psychiatric drug use and cognitive function, with adjustment for potential confounders, including routine demographic characteristics.
Results:: A total of 956 women during the menopausal transition were included in the analysis. As the number of psychotropic drugs used increased, cognitive function decline became more pronounced. Antidepressants and benzodiazepines played dominant roles in this association (posterior inclusion probability >0.9). The concurrent use of two or more psychotropic drugs was associated with an 11%–24% reduction in DSST cognitive scores. In the context of three-drug combinations, the cognitive impairment associated with antidepressants and benzodiazepines were amplified, resulting in an additional 5.1%–6.3% decrease in cognitive scores.
Conclusions:: Psychiatric medication use showed a significant cross-sectional association with poorer cognitive performance among women undergoing menopausal transition, and polypharmacy regimens displayed stronger associations than single-drug regimens. Clinically, greater attention should be paid to the potential cognitive impact of psychiatric drug use in menopausal women, and polypharmacy regimens should be optimised.
Related
- Menopausal symptoms, sexual function, and psychological well-being in women across the menopausal transition.
- The moderating effect of cognitive re-evaluation on the relationship between superficial performance and job burnout in psychiatric nurses
- Early Changes in Myocardial Mechanics and Diastolic Function in Women During the Menopausal Transition
- Longitudinal relationship between cognitive function and depressive symptoms in older adults: evidence from China.
- Alzheimer's disease neuropathological characterization of the dog brain and relationship to biofluid biomarkers and cognitive function.
BibTeX
@article{jiang2026relationship,
title = {{Relationship Between Psychiatric Drug Use and Cognitive Function in Women During the Menopausal Transition: An Analysis Based on the NHANES Database}},
author = {Yan Jiang and Hui Sun and Hui Ma and Chenyang Zhao},
journal = {Actas Españolas de Psiquiatría},
year = {2026},
month = oct,
doi = {10.62641/aep.2352},
url = {https://doi.org/10.62641/aep.2352},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Relationship Between Psychiatric Drug Use and Cognitive Function in Women During the Menopausal Transition: An Analysis Based on the NHANES Database
AU - Yan Jiang
AU - Hui Sun
AU - Hui Ma
AU - Chenyang Zhao
PY - 2026
DA - 2026/10/15
JO - Actas Españolas de Psiquiatría
DO - 10.62641/aep.2352
UR - https://doi.org/10.62641/aep.2352
AB - Background:: Women during the menopausal transition often experience mood disorders, sleep disturbances, and cognitive decline, making the use of psychotropic drugs relatively common. However, the relationship between psychiatric drug use and cognitive function in menopausal women remains unclear. Methods:: This was a cross-sectional study that included women aged 45–65 years from the National Health and Nutrition Examination Survey (NHANES) 2021–2023 cycle. Psychiatric drug use was defined based on prescription drug data, including antidepressants, benzodiazepines, and sedative-hypnotics. Cognitive function was assessed using the Digit Symbol Substitution Test (DSST). The Bayesian Kernel Machine Regression model was used to analyse the relationship between psychiatric drug use and cognitive function, with adjustment for potential confounders, including routine demographic characteristics. Results:: A total of 956 women during the menopausal transition were included in the analysis. As the number of psychotropic drugs used increased, cognitive function decline became more pronounced. Antidepressants and benzodiazepines played dominant roles in this association (posterior inclusion probability >0.9). The concurrent use of two or more psychotropic drugs was associated with an 11%–24% reduction in DSST cognitive scores. In the context of three-drug combinations, the cognitive impairment associated with antidepressants and benzodiazepines were amplified, resulting in an additional 5.1%–6.3% decrease in cognitive scores. Conclusions:: Psychiatric medication use showed a significant cross-sectional association with poorer cognitive performance among women undergoing menopausal transition, and polypharmacy regimens displayed stronger associations than single-drug regimens. Clinically, greater attention should be paid to the potential cognitive impact of psychiatric drug use in menopausal women, and polypharmacy regimens should be optimised.
SN - 1139-9287
SN - 1578-2735
ER -